# Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing Breast Cancer

> **NCT06492447** · — · NOT_YET_RECRUITING · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 50 (estimated)

## Conditions studied

- HER 2 Low-expressing Breast Cancer

## Interventions

- **DRUG:** Against HER 2-ADC Drug

## Key facts

- **NCT ID:** NCT06492447
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-04
- **Primary completion:** 2026-01-04
- **Final completion:** 2026-03-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06492447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06492447, "Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06492447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*